Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    .
    Human Health
    Startups
    .
    Non-R&D Companies
    Member Savings
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3232 results found
Expand All
Apply All
3232 results found

BIO Statement on Proposed Rule to Implement Comprehensive Outbound Investment National Security (COINS) Act
Share
Press Release  •  October 22, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) rule:"The Administration is correct that biotechnology is a strategic technology industry for the United States.  We need policies and initiatives that maintain and advance our global leadership in biotech, particularly as we compete with China.  The details of the proposed Treasury Department rules matter. We cannot restrict our way to success. As Treasury considers comments on the proposed rule, we need to ensure that we do not have an overly broad approach that would create uncertainty for innovators and investors, and that may unintentionally risk weakening U.S. biotech competitiveness. BIO is committed to continue working with policymakers to safeguard our national security and ensuring that America remains the world's leading engine of biomedical innovation and scientific discovery.”### 
Read More

BIO Patient Advocacy Changemakers Event
Share
Human Health, Patient Advocacy  •  Events  •  October 22, 2026
An exciting forum for patient advocacy organizations, policy stakeholders and biotech alliance development professionals.  Registration is free for patient advocacy organizations and BIO members, and topics include patient access to innovative medicines, incorporating patient voice into decision-making, and patient advocates’ important role in supporting their members and improving patients’ lives. 
Read More
BIO Patient & Health Advocacy Summit

BIOPAC
Share

BIOPAC: BIO Board Member Enrollment Form
Share

Thank You for Signing Up
Share
You’re all set to receive information about upcoming BIO events.If you have any questions, please contact customercare@bio.org.See upcoming BIO events
Read More

Become a BIO Member
Share

BIO Statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’
Share
Press Release  •  October 14, 2026
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step toward advancing regulatory approaches that better reflect the realities of rare disease drug development.“BIO has long advocated for fit-for-purpose approaches that maintain rigorous scientific standards while recognizing the challenges of small patient populations, complex diseases, and significant unmet need. For millions of patients and families facing a rare disease, time matters. Every delay can mean disease progression, lost opportunities, and more time waiting for a treatment that may change or save a life.“We applaud the FDA and HHS for this significant action and look forward to working with the Administration to help bring new therapies to patients faster while upholding the highest standards of safety and effectiveness.” 
Read More

BioTech Association of North Dakota (BiotechND)
Share
BIO Business Solutions - Member Association
Through its partnership with BIO, the BioTech Association of North Dakota (BiotechND) offers its members the opportunity to take advantage of the BIO Business Solutions® programs listed below. Click on the company name to learn more.There is no fee for BiotechND members to participate.
Read More

IRA fix would boost biosimilars
Share
Bio.News  •  October 13, 2026
Biosimilar legislation is designed to encourage innovation. Plus: Measles outbreaks drive demand for MMR vaccine. (1,094 words, 4 minutes, 23 seconds)
Read More

BioSafe Annual Meeting
Share
Human Health  •  Events  •  October 5, 2026
BioSafe annual meeting continues to serve members by promoting industry best practices and offering a forum for robust scientific exchange. We are back to an in-person meeting hosted and sponsored by Janssen R&D. We will also offer online/virtual participation.
Read More
BioSafe General Membership Meeting

Pagination

  • First First page
  • Prev Previous page
  • …
  • 4
  • 5
  • 6
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2026 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO